Pay in 4 interest-free payments of $6.90 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Efficacy and safety of the dual GIP and GLP-1 receptor agonist tirzepatide for weight loss: a meta-analysis of randomized controlled trials
The information below is sourced from FDA published statements and the Federal Register and is provided for educational context, not as a prediction about altRx's specific operations
But it could also be due to your diet or current medication
Although these changes in HR upon GLP-1 RA administration were subtle and the underlying mechanisms are unclear, further studies are necessary to elucidate the long-term effects of GLP-1 RAs primarily on HR and other related variables to clarify whether the elevated HR can be regarded as a transient reflex mechanism or whether it might in fact lead to poor cardiovascular outcomes in a diabetic population
K.WuY.et al (2004)
It's important to understand that this program works outside of your regular Part D drug benefit
US$ 22.78
US$ 25.18
US$ 29.00
US$ 22.61
